A two-dose primary schedule without booster can provide sufficient protection in high-transmission, resource-limited settings ...

Pneumococcal infections can be very serious – they include pneumonia, meningitis, and bacteremia (a blood infection), as well ...

South Korea's top court clears SK Bioscience’s vaccine of patent violation, unlocking export potential and global market ...

Some five years into a pneumococcal vaccine patent dispute in South Korea, SK Bioscience has emerged victorious over Pfizer.

Seongnam: SK bioscience, a global vaccine and biotech company, has announced that the Supreme Court of Korea has ruled in its ...

Pneumococcal meningitis was associated with a case-fatality rate of almost 30% in children with sickle cell disease, a study ...

South Sudan has introduced the pneumococcal conjugate vaccine (PCV) and rotavirus vaccine into its national immunization ...

South Korean vaccine company SK Bioscience said it has prevailed in a lawsuit brought by Pfizer that accused it of infringing on the patent for the drugmaker's Prevnar 13 vaccine.

Vaccine and biotech company SK bioscience announced Wednesday that it the Supreme Court of Korea has ruled in its favor in a patent infringement lawsuit filed by large ...